8 completed. 8 Phase 1.
By phase and status
Follow tenapanor: new trials by email Literature Review of tenapanor trials Research Report on tenapanor
Trials (filtered) newest first · largest first
All 8 trials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
An Open-label Study to Evaluate the Pharmacokinetics of Oral Tenapanor in Breast Milk of Lactating Females Tenapanor - Lactation | Phase 1 | Completed | 7 | 2023-11-27 | 2024-07-11 |
To Evaluate the Effect of AZD1722 on the Pharmacokinetics of Oral Midazolam in Healthy Volunteers Midazolam, AZD1722, AZD1722 and Midazolam - Healthy Volunteers | Phase 1 | Completed | 65 | 2014-05-01 | 2015-09-22 |
AZD1722 Open Label, Absorption Distribution Metabolism and Excretion Study AZD1722 - Healthy Volunteers | Phase 1 | Completed | 26 | 2014-04-01 | 2015-09-22 |
Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects AZD1722, Placebo - Healthy Volunteer | Phase 1 | Completed | 83 | 2013-07-01 | 2014-06-27 |
A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722 AZD1722, Renvela - Healthy | Phase 1 | Completed | 16 | 2013-04-01 | 2015-01-27 |
A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations AZD1722, Omeprazole - Healthy | Phase 1 | Completed | 18 | 2013-02-01 | 2014-09-26 |
Safety, Tolerability, and Pharmacodynamics of RDX5791 in Healthy Volunteers RDX5791, Placebo - Healthy | Phase 1 | Completed | 105 | 2011-07-01 | 2016-06-10 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RDX5791 in Healthy Volunteers RDX5791, Placebo - Healthy | Phase 1 | Completed | 80 | 2010-11-01 | 2016-06-30 |
Conditions studied
Breast Feeding (1)
Sponsors
Ardelyx (8)
Countries
United States (5) · United Kingdom (1)
Top investigators
David P Rosenbaum, Ph.D. (3) · David P. Rosenbaum, Ph.D (2) · Eleanor Lisbon, MD (1) · Susan Edelstein, PhD (1)
Results publications
PMID 29363027, PMID 27368672